Now, there is a complex global situation where populations in different countries have unique hybrid immunity landscapes, born from a wide range of vaccination history and exposure history combinations.
In 2023, we needed to consider what hybrid immunity meant for booster vaccinations. And what different types of hybrid immunity meant for future vaccination strategies.
In a notice on its website, the European Medicines Agency also announced the withdrawal, which means that Vaxzevria is no longer authorized to be marketed or sold in European Union countries.
... a new meta-analysis of six randomized controlled trials in JAMA Neurology finds no increase in seizures in the month following COVID vaccination.
...
The findings suggest that there is no difference in risk of seizure incidence among vaccinated individuals vs placebo recipients," the authors concluded. "However, the risk of seizure occurrence after SARS-CoV-2 infection seems to be relatively high."
Moreover, 60.8% expressed being more willing to get vaccinated for diseases other than COVID-19 as a result of their experiences during the pandemic, while 23.1% reported being less willing. ...
The most widely circulating COVID variant worldwide is now JN.1, having overtaken the XBB family that is the target of the most recent vaccines, the European Medicines Agency said.
The analysis also found that spikes in the number of negative tweets coincided with announcements from governments and health care authorities about vaccination.
